myDexTrial Log In
Explore Trials
For Patients
For Physicians
Our Solutions
About Us
myDexTrial Log In
Explore Trials
Explore
our Featured Trials
Filter: selected
12
Country
Germany
Austria
Switzerland
Indonesia
Latvia
Qatar
Therapeutic Areas
Neurology
Rheumatology
Gastrointestinal Disease
Immunology
(Ultra-) Rare Disease
Haematology
Trial / Investigated Product Type
Immunology
(Ultra-) Rare Disease
Haematology
Healthy Volunteers
Immunology
(Ultra-) Rare Disease
Haematology
Trial Phase
Recruiting
Not Recruiting
Trial Completed
Neurology
Rheumatology
Gastrointestinal Disease
Sorting:
All
Premium
Default
NCT04628026
Recruiting
Acute Myeloid Leukemia
Interventional
Drug
+4
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Keywords:
tag1
tag2
Countries:
Germany
Austria
Switzerland
NCT04628026
Recruiting
Acute Myeloid Leukemia
Interventional
Drug
+4
Test trial
Countries:
Germany
Austria
Switzerland
1
2
3
4
5
